Subfoveal Neovascular Age-Related Macular Degeneration

1 clinical trials · Condition

Record	Firm	Date
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) (NCT01025232)	David M. Brown, M.D.	2009-12-01

Every clearance here is in the API, with alerts when new ones post.